phytonadione · Pai Holdings Pharm · NDA 012223

Aquamephyton

Earliest generic entry, as listed · earliest of 2 marketed strengths
Open now

No marketed reference-listed strength; date taken from all listed strengths.

No unexpired patents or exclusivities are listed for this product.

Listed patents · 0 unexpired

No unexpired patents listed.

Exclusivities · 0 unexpired

No unexpired exclusivities listed.

Paragraph IV certifications · 0

No Paragraph IV certification listed by FDA for this drug.

The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.

Event history

  • Generic approved · ANDA 216852, Baxter Hlthcare Corp · 012223-001Approved 26 Feb 2026Detected 25 Oct 2026Historical import
  • Generic approved · ANDA 215090, Sunny · 012223-001Approved 9 Jan 2026Detected 25 Oct 2026Historical import
  • Generic approved · ANDA 216298, Orbicular · 012223-001Approved 13 Mar 2026Detected 25 Oct 2026Historical import
  • Generic approved · ANDA 215820, Dr Reddys · 012223-001Approved 15 May 2026Detected 25 Oct 2026Historical import
  • Generic approved · ANDA 216601, Amneal · 012223-001Approved 4 Nov 2025Detected 25 Oct 2026Historical import
  • Generic approved · ANDA 219175, Lupin · 012223-001Approved 30 Sep 2026Detected 25 Oct 2026Historical import
  • Generic approved · ANDA 217734, Amneal · 012223-001Approved 1 Jun 2026Detected 25 Oct 2026Historical import

Products covered · 2

NDA · productFormStrengthListed expiry
012223 · 001 · RLD · discontinuedinjectable, injection10MG/ML ***Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**open
012223 · 002 · RLD · discontinuedinjectable, injection1MG/0.5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**open